Amundi
PROK icon

Amundi’s ProKidney PROK Stock Holding History

Amundi’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Buy
291,708
+19,466
+7% +$41.3K ﹤0.01% 1534
2025
Q4 		$610K Buy
+272,242
New +$716K ﹤0.01% 1407
2025
Q2 		– Sell
-155,953
Closed -$111K – 2056
2025
Q1 		$111K Hold
155,953
– – ﹤0.01% 1735
2024
Q4 		$259K Hold
155,953
– – ﹤0.01% 1688
2024
Q3 		$270K Buy
155,953
+155,812
+110,505% +$354K ﹤0.01% 1586
2024
Q2 		$330 Sell
141
-78,043
-100% -$209K ﹤0.01% 1915
2024
Q1 		$188K Buy
78,184
+6,341
+9% +$9.31K ﹤0.01% 1645
2023
Q4 		$114K Buy
71,843
+16,341
+29% +$35K ﹤0.01% 1748
2023
Q3 		$154K Buy
55,502
+13,125
+31% +$126K ﹤0.01% 1663
2023
Q2 		$486K Buy
42,377
+4,508
+12% +$48K ﹤0.01% 1398
2023
Q1 		$346K Buy
37,869
+14,047
+59% +$150K ﹤0.01% 1432
2022
Q4 		$182K Buy
+23,822
New +$228K ﹤0.01% 1529

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amundi's PROK Position: Q1 2026 in Review

Amundi increased its ProKidney (PROK) stake by 7.2% in Q1 2026, buying an estimated $41.3K and bringing the position to 291,708 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Amundi first reported a position in PROK in Q4 2022 and has held it in 12 quarters since. The position peaked at $610K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Amundi held 291,708 shares of ProKidney worth $522K as of Q1 2026.
  • Amundi bought 19,466 ProKidney shares in Q1 2026, an estimated $41.3K.
  • ProKidney made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1534 holding.
  • Amundi first reported a position in ProKidney in Q4 2022 and has held it in 12 quarters since.
  • Amundi's ProKidney position peaked at $610K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.